Glomerular and tubular function in renal transplant patients treated with and without ciclosporin A

被引:26
作者
Hansen, JM
Fogh-Andersen, N
Leyssac, PP
Strandgaard, S
机构
[1] Herlev Hosp, Dept Nephrol, DK-2730 Herlev, Denmark
[2] Herlev Hosp, Dept Clin Physiol & Nucl Med, DK-2730 Herlev, Denmark
[3] Herlev Hosp, Dept Clin Chem, DK-2730 Herlev, Denmark
[4] Univ Copenhagen, Inst Med Physiol, Div Renal & Cardiovasc Physiol, DK-1168 Copenhagen, Denmark
关键词
ciclosporin; effective renal plasma flow; glomerular filtration rate; lithium clearance; magnesium clearance; renal transplant recipients; sodium clearance; urate clearance;
D O I
10.1159/000045219
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The present study evaluated whether chronically administered low-dose (<5 mg/kg) ciclosporin A (CsA) affects renal haemodynamics and tubular function in renal transplant recipients (RTx) when studied at nadir CsA blood levels. The renal clearance of lithium was used as an index of proximal tubular outflow of sodium and water. Effective renal plasma flow, glomerular filtration rate, and renal clearance of lithium were studied in 67 stable non-diabetic RTx and 44 healthy controls. Forty-eight of the RTx were treated with CsA, prednisone, and azathioprine. Nineteen were treated exclusively with prednisone and azathioprine. In RTx with a good graft function (serum-creatinine <125 mu mol/l), no specific CsA-induced renal haemodynamic and tubular dysfunctions were evident. In CsA-treated RTx with a slightly reduced renal function (serum creatinine 125-180 mu mol/l) a decrease in fractional proximal tubular reabsorption was found. The renal clearances of urate and magnesium were comparable between RTx treated with or without CsA, and a significant correlation between glomerular filtration rate and renal clearance of urate was found. CsA-treated RTx had a significantly higher blood pressure, independent of glomerular filtration rate and segmental tubular function. In conclusion, at nadir CsA blood levels, no specific CsA-induced tubular dysfunction evaluated by the renal lithium clearance method could be demonstrated in RTx receiving chronically low-dose CsA. The hyperuricaemia commonly seen in RTx seems to be mainly caused by the reduced glomerular filtration rate.
引用
收藏
页码:450 / 457
页数:8
相关论文
共 27 条
[1]
HYPOMAGNESEMIA AND RENAL MAGNESIUM WASTING IN RENAL-TRANSPLANT RECIPIENTS RECEIVING CYCLOSPORINE [J].
BARTON, CH ;
VAZIRI, ND ;
MARTIN, DC ;
CHOI, S ;
ALIKHANI, S .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (04) :693-699
[2]
BATLLE DC, 1986, CLIN NEPHROL, V25, pS62
[3]
CANZANELLO VJ, 1995, J AM SOC NEPHROL, V5, P1910
[4]
CYCLOSPORINE IN THERAPEUTIC DOSES INCREASES RENAL-ALLOGRAFT VASCULAR-RESISTANCE [J].
CURTIS, JJ ;
DUBOVSKY, E ;
WHELCHEL, JD ;
LUKE, RG ;
DIETHELM, AG ;
JONES, P .
LANCET, 1986, 2 (8505) :477-479
[5]
NEPHROTOXICITY OF CYCLOSPORINE-A - A LITHIUM CLEARANCE AND MICROPUNCTURE STUDY IN RATS [J].
DIEPERINK, H ;
LEYSSAC, PP ;
STARKLINT, H ;
KEMP, E .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1986, 16 (01) :69-77
[6]
NEPHROTOXICITY OF CYCLOSPORINE-A IN HUMANS - EFFECTS ON GLOMERULAR-FILTRATION AND TUBULAR REABSORPTION RATES [J].
DIEPERINK, H ;
LEYSSAC, PP ;
KEMP, E ;
STARKLINT, H ;
FRANDSEN, NE ;
TVEDES, N ;
MOLLER, J ;
FREDERIKSEN, PB ;
ROSSING, N .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1987, 17 (06) :493-496
[7]
PROXIMAL TUBULAR FUNCTION IN RATS WITH LOW INULIN CLEARANCE [J].
GOTTSCHA.CW ;
LEYSSAC, PP .
ACTA PHYSIOLOGICA SCANDINAVICA, 1968, 74 (03) :453-&
[8]
Cyclosporine-induced hypertension and decline in renal function in healthy volunteers [J].
Hansen, JM ;
FoghAndersen, N ;
Christensen, NJ ;
Strandgaard, S .
JOURNAL OF HYPERTENSION, 1997, 15 (03) :319-326
[9]
Effects of the prostacyclin analogue iloprost on cyclosporin-induced renal hypoperfusion in stable renal transplant recipients [J].
Hansen, JM ;
Christensen, NJ ;
FoghAndersen, N ;
Strandgaard, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (02) :340-346
[10]
Renal effects of amino acids and dopamine in renal transplant recipients treated with or without cyclosporin A [J].
Hansen, JM ;
Olsen, NV ;
Leyssac, PP .
CLINICAL SCIENCE, 1996, 91 (04) :489-496